Jeff Johnson

Stock Analyst at Baird

(2.13)
# 729
Out of 5,320 analysts
156
Total ratings
52.08%
Success rate
21.66%
Average return
17 Stocks
Name Action Price Target Current % Upside Ratings Updated
COO Cooper Companies
Maintains: Outperform
117 107
78.74 35.89% 16 Mar 7, 2025
TNDM Tandem Diabetes Care
Maintains: Neutral
37 33
16.41 101.1% 15 Feb 27, 2025
ALC Alcon
Maintains: Outperform
104 108
91.42 18.14% 9 Feb 27, 2025
DXCM DexCom
Upgrades: Outperform
86 104
66.11 57.31% 13 Jan 16, 2025
PDCO Patterson Cos
Maintains: Neutral
25 31
31.33 -1.05% 7 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 22
14.88 47.85% 7 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
378 405
339.88 19.16% 11 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
325 276
171.66 60.78% 16 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
155 145
96.38 50.45% 13 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
92 82
63.11 29.93% 9 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
180 238
238.61 -0.26% 12 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
67 70
32.2 117.39% 2 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 61
14.81 311.88% 4 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 67
12.81 423.03% 6 Feb 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
56
39.75 40.88% 7 Oct 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
178
n/a n/a 6 Oct 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 31
n/a n/a 3 Nov 11, 2019